![Don't Phos Over Tau”: recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer's disease and other tauopathies | Molecular Neurodegeneration | Full Text Don't Phos Over Tau”: recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer's disease and other tauopathies | Molecular Neurodegeneration | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs13024-021-00460-5/MediaObjects/13024_2021_460_Fig3_HTML.png)
Don't Phos Over Tau”: recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer's disease and other tauopathies | Molecular Neurodegeneration | Full Text
![Phospho-Tau (Ser404) Polyclonal Antibody, Invitrogen 100 μL; Unconjugated:Antibodies, | Fisher Scientific Phospho-Tau (Ser404) Polyclonal Antibody, Invitrogen 100 μL; Unconjugated:Antibodies, | Fisher Scientific](https://assets.fishersci.com/TFS-Assets/LSG/antibodies/PA5-121266-TAU-WB-1-20220207_161809.jpg-650.jpg)
Phospho-Tau (Ser404) Polyclonal Antibody, Invitrogen 100 μL; Unconjugated:Antibodies, | Fisher Scientific
![Pathologically phosphorylated tau at S396/404 (PHF-1) is accumulated inside of hippocampal synaptic mitochondria of aged Wild-type mice | Scientific Reports Pathologically phosphorylated tau at S396/404 (PHF-1) is accumulated inside of hippocampal synaptic mitochondria of aged Wild-type mice | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-83910-w/MediaObjects/41598_2021_83910_Fig1_HTML.png)